226 related articles for article (PubMed ID: 37399508)
1. RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway.
Ye F; Niu X; Liang F; Dai Y; Liang J; Li J; Wu X; Zheng H; Qi T; Sheng W
Brain; 2023 Nov; 146(11):4674-4689. PubMed ID: 37399508
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease.
Bang OY; Chung JW; Kim SJ; Oh MJ; Kim SY; Cho YH; Cha J; Yeon JY; Kim KH; Kim GM; Chung CS; Lee KH; Ki CS; Jeon P; Kim JS; Hong SC; Moon GJ
Int J Stroke; 2016 Dec; 11(9):999-1008. PubMed ID: 27462098
[TBL] [Abstract][Full Text] [Related]
3. Moyamoya Disease Susceptibility Gene
Roy V; Ross JP; Pépin R; Cortez Ghio S; Brodeur A; Touzel Deschênes L; Le-Bel G; Phillips DE; Milot G; Dion PA; Guérin S; Germain L; Berthod F; Auger FA; Rouleau GA; Dupré N; Gros-Louis F
Stroke; 2022 Apr; 53(4):1263-1275. PubMed ID: 34991336
[TBL] [Abstract][Full Text] [Related]
4. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
Kobayashi H; Matsuda Y; Hitomi T; Okuda H; Shioi H; Matsuda T; Imai H; Sone M; Taura D; Harada KH; Habu T; Takagi Y; Miyamoto S; Koizumi A
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26126547
[TBL] [Abstract][Full Text] [Related]
7. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
[TBL] [Abstract][Full Text] [Related]
8. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
Elife; 2020 Jun; 9():. PubMed ID: 32573437
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
[TBL] [Abstract][Full Text] [Related]
10. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
[TBL] [Abstract][Full Text] [Related]
11. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.
Ito A; Fujimura M; Niizuma K; Kanoke A; Sakata H; Morita-Fujimura Y; Kikuchi A; Kure S; Tominaga T
Brain Res; 2015 Jan; 1594():310-20. PubMed ID: 25446450
[TBL] [Abstract][Full Text] [Related]
12. RNF213 Loss-of-Function Promotes Angiogenesis of Cerebral Microvascular Endothelial Cells in a Cellular State Dependent Manner.
Roy V; Brodeur A; Touzel Deschênes L; Dupré N; Gros-Louis F
Cells; 2022 Dec; 12(1):. PubMed ID: 36611871
[TBL] [Abstract][Full Text] [Related]
13. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of
Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
[No Abstract] [Full Text] [Related]
15. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.
Kim WH; Kim SD; Nam MH; Jung JM; Jin SW; Ha SK; Lim DJ; Lee HB
Childs Nerv Syst; 2019 Feb; 35(2):309-314. PubMed ID: 30283986
[TBL] [Abstract][Full Text] [Related]
16. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
[TBL] [Abstract][Full Text] [Related]
17. RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses.
Zhang L; Rashad S; Zhou Y; Niizuma K; Tominaga T
J Cereb Blood Flow Metab; 2022 Nov; 42(11):2107-2122. PubMed ID: 35754359
[TBL] [Abstract][Full Text] [Related]
18. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
19. A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213.
Strong A; O'Grady G; Shih E; Bishop JR; Loomes K; Diamond T; Hartung EA; Wong W; Cuddapah S; Cahill AM; Hou C; Slater D; Vaccaro C; Watson D; Li D; Hakonarson H
Am J Med Genet A; 2021 Jul; 185(7):2168-2174. PubMed ID: 33960657
[TBL] [Abstract][Full Text] [Related]
20. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.
Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T
Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
